glp-1 approved for type 1 diabetes More people with are using drugs, study finds, despite limited evidence on safety or effectiveness Scripts for GLP-1, SGLT2 Drugs

Regulated expression and function of the GABA B receptor in human pancreatic cell line and islets

One particularly notable case report described a 23-year-old female who developed alopecia areata, an autoimmune form of hair loss, just two months after starting semaglutide

This echoes the findings of a 2013 review, which found neither firm evidence in favor of this hypothesis nor evidence strong enough to rule out any such increased risk. Recent research also points to a link between the GLP-1 receptor agonist semaglutide and worsening diabetic retinopathy (DR)

Extended Data Figure 4 Effects of binding pocket mutations on potency of NAMs

Make Strategic Foresight a Competitive Weapon The GLP-1 landscape is evolving rapidly